
Podcast #186 · 27 Aug 2024
Blue Light Cystoscopy: Improving Bladder Cancer Detection
- Transurethral Resection of Bladder Tumor (TURBT)
- Urologic Oncology
- Non-Muscle Invasive Bladder Cancer (NMIBC)
- Blue Light Cystoscopy
- Bladder Cancer
What is the role of blue light cystoscopy in bladder cancer? In this episode, Dr. Suzette Sutherland interviews Dr. Suzanne Merrill from Colorado Urology about the benefits of this technology in the diagnosis and treatment of bladder cancer, and how to implement it into your practice.
This podcast is supported by
Timestamps
Resources
More about this episode
The doctors start by discussing the advantages of using blue light cystoscopy, including better detection rates of Ta and T1 lesions and the reduction of cancer recurrence by as much as 11%. They highlight the importance of complete transurethral resection of bladder tumor (TURBT) and patient compliance. Dr. Merrill emphasizes the necessity of accurate risk stratification and the logistics of real-life incorporation. Finally, she also comments on new bladder cancer technologies, such as narrow band imaging.

